0000950170-24-076263.txt : 20240621
0000950170-24-076263.hdr.sgml : 20240621
20240621162007
ACCESSION NUMBER: 0000950170-24-076263
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240620
FILED AS OF DATE: 20240621
DATE AS OF CHANGE: 20240621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Levy Elliott M.
CENTRAL INDEX KEY: 0001858745
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40657
FILM NUMBER: 241060677
MAIL ADDRESS:
STREET 1: C/O OMEGA THERAPEUTICS, INC.
STREET 2: 20 ACORN PARK D
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Omega Therapeutics, Inc.
CENTRAL INDEX KEY: 0001850838
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 140 FIRST STREET, SUITE 501
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: (617) 949-4360
MAIL ADDRESS:
STREET 1: 140 FIRST STREET, SUITE 501
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
4
1
ownership.xml
4
X0508
4
2024-06-20
0001850838
Omega Therapeutics, Inc.
OMGA
0001858745
Levy Elliott M.
C/O OMEGA THERAPEUTICS, INC.
140 FIRST STREET, SUITE 501
CAMBRIDGE
MA
02141
true
false
false
false
false
Stock Option (Right to Buy)
2.20
2024-06-20
4
A
false
25000
0.00
A
2034-06-19
Common Stock
25000
25000
D
The options vest and become exercisable on the earlier of (i) the date of the Issuer's next annual meeting of stockholders and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.
/s/ Barbara Chan as Attorney-in-Fact for Elliott Levy
2024-06-21